Variable | Groups | ||
---|---|---|---|
HC | RA | SLE | |
Patients/individuals (n) | 30 | 25 | 59 |
Age (years), median (range) | 32 (19–80) | 30 (21–72) | 34 (11–87) |
Sex (F/M) | 29/1 | 24/1 | 57/2 |
ANA test | |||
 ANA+ (patients with positive ANA), n (%) |  |  | 48 (81.4%) |
 ANA− (patients with negative ANA), n (%) |  |  | 11 (18.6%) |
Diagnosis based on renal involvement | |||
 LN patients |  |  | 23 (40.4%) |
 Non-LN patients |  |  | 36 (59.6%) |
Disease status | Â | Â | Â |
 Active patients (SLEDAI ≥ 5), n (%) |  |  | 27 (45.8%) |
 Stable patients (SLEDAI < 5), n (%) |  |  | 32 (54.2%) |